Upload Avatar (500 x 500)
Jun Zhang
Basic Medical Sciences
Peking University
Beijing
Language: Chinese, English
Inflammation
Immunology
Cancer
Regulation
Tumor
Immune Response
Cell Signaling
Molecular Biology
Pathogenesis
Therapy
Areas of Focus
- Inflammation regulation and cancer immunology
Work Experience
- 2004-present - Peking University, Faculty of Medicine: Associate Professor, Professor
Academic Background & Achievements
- 2001 - PhD in Immunology from Peking University
- 2001-2004 - Postdoctoral Research in Immunology at the Jewish Medical Center, USA
- Funded projects include Ministry of Science and Technology '863' project, 5 National Natural Science Foundation projects, and more
Publications
- USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling, Jun Zhang*, 2018
- PDCD5 regulates iNKT cell terminal maturation and iNKT1 fate decision, Jun Zhang*, 2018
- Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell, Jun Zhang*, 2018
- Inflammasomes in Inflammation-Induced Cancer, Jun Zhang*, 2017
- Smurf2 negatively modulates RIG-I-dependent anti-viral response by targeting VISA/MAVS for ubiquitination and degradation, Jun Zhang*, 2014
- The tumor suppressive function of UNC5D and its repressed expression in renal cell carcinoma, Jun Zhang*, 2013
- PIAS1 negatively modulates virus triggered type I IFN signaling by blocking the DNA binding activity of IRF3, Jun Zhang*, 2013
- Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma, Jun Zhang*, 2011
- CHP2 activates the calcineurin/NFAT signaling pathway and enhances the oncogenic potential of HEK293 cells, Jun Zhang*, 2008
Awards
- 2013 - Ministry of Education New Century Excellent Talents
- 2014 - Peking University Outstanding Young Talent Award
- Various teaching and research awards at Peking University
